Background {#Sec1}
==========

Since it emerged in the eighteenth century, the discipline of orthopedic surgery has been remarkably developed \[[@CR1]\]. Till now, several orthopedic surgeries have been explored, including total knee replacement, hip fracture, and total hip replacement \[[@CR2]\]. However, there are still some deficiencies to limit the application of orthopedic surgery in clinic, such as pain control, prevention of post-operative nausea or vomiting (PONV), rapid recovery, cognitive impairment, and surgical site infection \[[@CR3]--[@CR5]\]. Specifically, anesthesia is a common procedure during orthopedic surgery, which could affect the temperature regulation, infection, bleeding, oxygen consumption, and other complications to influence the outcome of orthopedic surgery \[[@CR6]\]. Therefore, it is important to innovate appropriate anesthesia manner to improve the outcomes and prognosis of orthopedic surgery.

With the development of few decades, although several anesthesia manners have been explored for orthopedic surgery, the complications of anesthesia are still not well resolved. A previous study has revealed that patients managed with general anesthesia perform a low risk of complications compared with patients undergoing spinal anesthesia during the total knee arthroplasty \[[@CR7]\]. However, compared with the general anesthesia, regional anesthesia presents a better outcome than general anesthesia in total hip arthroplasty, including reductions of deep surgical site infection, length of hospital stay, and pulmonary complication \[[@CR8]\]. Moreover, Stundner et al. have revealed that neuraxial anesthesia reduces the occurrence rates of blood transfusions and morbidity in the perioperative period of compared with general anesthesia for simultaneous bilateral total knee arthroplasty \[[@CR9]\]. In addition, Ewan et al. have documented that general anesthesia increases the risk of post-operative cognitive dysfunction compared with other anesthesia methods \[[@CR10]\]. Considering of these evidences, there is still no clear consensus in anesthesia during orthopedic surgery.

In the current study, a network meta-analysis was performed to comprehensively estimate the effects of different anesthesia manners, such as general anesthesia on the outcomes of orthopedic surgery. According to this analysis, we hope to provide some new insights for improving the outcomes of orthopedic surgery.

Methods {#Sec2}
=======

Data sourcing {#Sec3}
-------------

According to the searching strategy, studies focused on the associations between anesthesia methods and adverse effects after orthopedic surgery published in English were downloaded from the Pubmed (<http://www.ncbi.nlm.nih.gov/pubmed>), Embase (<http://www.embase.com>), and the Cochrane Library (<http://www.cochranelibrary.com>) databases. The searching date was ranged from its recording to Mar. 10th, 2018. The searching strategy was designed as follows: "general anesthesia" (OR "general anaesthesia" OR "local anesthesia" OR "topical anesthesia" OR "local anaesthesia" OR "toponarcosis" OR "medullary anesthesia" OR "rachianalgesia" OR "rachianesthesia" OR "medullary narcosis" OR "spinal anesthesia" OR "rhachiaesthesia" OR "rhachianalgesia" OR "lumbar anesthesia" OR "epidural anesthesia" OR "epidural block" OR "epidural anaesthesia" OR "caudal anaesthesia" OR "caudal anesthesia" OR "caudalanaesthesia" OR "infiltration analgesia" OR "intrathecal analgesia") AND "orthopedics" (OR "orthopedic" OR "osteology") AND "Rando".

Inclusive and exclusive criteria {#Sec4}
--------------------------------

In the present study, studies were included if they met the following terms: (1) published in English; (2) reported on the influences of different anesthesia methods on the effective of patients (P) undergoing orthopedic surgery; (3) patients in different groups receiving different anesthesia methods (Intervention, I; and Control, C); (4) study outcome variables including PONV, urine retention, back pain, sore throat, and headache, and so on (Outcomes, O); and (5) randomized controlled trial (RCT; S). Studies were excluded if they were met the following criteria: (1) incomplete data which could not be used for statistical analysis; (2) reviews, letters and comments; (3) for duplicate publication or data used for several studies, only the study with complete data was included, and others were excluded.

Data extraction and quality assessment {#Sec5}
--------------------------------------

Data was independently extracted from the included studies by two censors in this study, respectively. The extracted information included the first author, published year, study year, study area, anesthesia method, sample size in different groups, length of operation, and the demographic characteristics of included patients, including age, gender, height, weight and so on. Quality of the enrolled studies were assessed using the Cochrane Collaboration recommendations recommended by the Cochrane system \[[@CR11]\]. During the data extraction and quality assessment, divergences were solved by discussing with the third censors.

Statistical analyses {#Sec6}
--------------------

ADDIS is a non-programming software based on Bayesian framework, and can be used for data evaluation using the Markov chain Monte Carlo theory \[[@CR12], [@CR13]\]. All data in the current study was analyzed using the ADDIS software (version 1.16.5), and presented with odd ratio (OR) and 95% confidence interval (CI). For *P* \< 0.05 in node-splitting analysis, the random effects model was used to calculate pooled effect size; otherwise, the consistency model were used to calculate the pooled effect size. Convergence degree of model was estimated using Brooks-Gelman-Rubin method, and presented with the potential scale reduction factor (PSRF). The more PSRF approximate to 1, the better convergence was obtained \[[@CR14]\].

Results {#Sec7}
=======

Characteristics of enrolled studies {#Sec8}
-----------------------------------

According to the searching strategy, a total of 3196 studies were recruited in this study. After removing the repetitions, 1945 studies were obtained. Following this, 1779 papers among 1945 were rejected after scanning title and abstract. Subsequently, 143 studies among remains were removed after reviewing the full text. Finally, 23 studies were obtained \[[@CR15]--[@CR37]\] and the process of study enrollment was presented in Fig. [1A](#Fig1){ref-type="fig"}.Fig. 1Study enrollment and quality assessment. **a**, Flow chart of study enrollment; **b**, Quality assessment of enrolled studies

Characteristics of the enrolled studies were summarized in Table [1](#Tab1){ref-type="table"}. For these enrolled studies, the published years of them were ranged from 1978 to 2017, and the research areas were concentrated on Germany, Japan, America, China, French, and Turkey. A total of 2393 patients were enrolled in this study, including 753 in general anesthesia (GA) group, 215 in epidural anesthesia (EA) group, 473 in local infiltration analgesia (LIA) group, 238 in nerve block analgesia (NBA) group, 630 in spinal anesthesia (SA) group, 65 in interscalene block (ISB) group, and 81 in GA + ISB group. Moreover, the number of male patients was slightly higher than female patients, but there was no significantly difference for gender ratio in each study. In addition, there were no significantly difference identified in the age, height, weight, and length of operation among groups. Quality assessment indicated that the enrolled studies presented an ordinary quality (Fig. [1B](#Fig1){ref-type="fig"}). Despite the random sequence generation (selection bias), most of studies didn't report more information on other quality assessment terms.Table 1Characteristics of enrolled studiesAuthorPublic YearLocationStudy YeatGroupNAge (years)\*Male/FemaleWeight(kg)\*Height (cm)\*Length of operation (min)\*Arcioni R2007Italy2004.9--2004.12EA2559.1 ± 19.412/1368.0 ± 8.7166.2 ± 8.4NASA2360.2 ± 21.29/1468.3 ± 10.4164.7 ± 7.9NAKuchalik J2013SwedenNASA3966(51--84)23/1684 ± 23170 ± 10106 ± 17LIA3967(50--85)21/1886 ± 20173 ± 8112 ± 28Dadure C2006France2001.7--2002.12EA271--12NA7--5672--16065--190NBA251--11NA10--5280--15145--180Dunn WR2006USANALIA18Mean:5111/7Mean:75.0Mean:170.3Mean:27.4SA14Mean:555/9Mean:74.2Mean:169.6Mean:30.9Hadzic A2005USA2000.4--2002.3ISB2549 ± 1317/885 ± 20173 ± 10127 ± 35GA2549 ± 1213/1286 ± 21172 ± 10147 ± 49Hadzic A2004USANANBA2545 ± 1512/1381 ± 18173 ± 1072(50--165)GA2540 ± 1611/1477 ± 15170 ± 1070(30--330)Janssen H2014GermanyNAGA4251 ± 1019/2380 ± 14170 ± 756.0 ± 12.4GA + ISB4153 ± 918/2381 ± 16170 ± 846.0 ± 15.3Karaarslan S2015TurkeyNASA3043 ± 1313/1775 ± 13170 ± 779 ± 22NBA3043 ± 1019/1177 ± 16169 ± 985 ± 23Krobbuaban B2005ThailandNASA8641 ± 2045/4158 ± 13161 ± 886 ± 52GA8538 ± 1747/3856 ± 8168 ± 771 ± 15Lehmann LJ2014Germany2011.7--2012.5GA4054.1 ± 11.722/1883.3 ± 16.6172.6 ± 10.7NAISB4049.3 ± 13.627/1388.2 ± 19.2172.2 ± 9.9NAGA + ISB4053.8 ± 15.218/2281.5 ± 16.3169 ± 9.8NANagafuchi M2015Japan2012.10--2013.7NBA1772 ± 102/1555 ± 8.2NA71 ± 15LIA1673 ± 5.93/1362 ± 12.5NA81 ± 20Seeberger MD1994SwitzerlandNASA9633.7 ± 12.373/2373.7 ± 12.6174.2 ± 5.362 ± 35EA9632.0 ± 9.067/2972.7 ± 11.0174.7 ± 5.468 ± 46Spangehl MJ2015NANANBA7967.8 ± 7.941/37NANANALIA8167.7 ± 7.248/43NANANAStandl T1996GermanyNASA22141.3 ± 17.8112/10970.4 ± 11170.5 ± 8120 ± 19GA21243.2 ± 17.3106/10670.9 ± 9172.1 ± 6116 ± 5Gi E2014JapanNALIA2577 ± 724/161 ± 13149 ± 7174 ± 23NBA2478 ± 521/364 ± 13151 ± 7173 ± 27Bigler D1985NANAGA2077.6 ± 2.35/15NANA59 ± 10SA2080.1 ± 1.62/18NANA67 ± 8Hole A1980NorwayNAGA3171.7(61--82)11/20NANA207 ± 6EA2969.9(56--84)10/19NANA190 ± 6Kudoh A2004JapanNASA7575.9 ± 4.069/660.4 ± 8.7151.3 ± 7.3106.7 ± 31.5GA7575.1 ± 4.266/959.2 ± 5.9149.3 ± 5.4104.2 ± 11.8McLaren AD1978UKNAGA2976 ± 9.7NANANANASA2675.6 ± 10.3NANANANATanikawa H2014JapanNALIA2371(69--76)19/455.0(53.5--66.0)151(148--152)82.4 ± 26.0NBA2372(67.5--76.5)20/354.5(48.0--66.5)150(143.5--155.5)75.0 ± 27.3Trker G2003TurkeyNAEA1562.2 ± 6.69/672.2 ± 7.5166.6 ± 3129.2 ± 26.4NBA1562.3 ± 7.28/773.7 ± 6.3167.4 ± 4.4131.3 ± 18.7Wang H2017China2008.1--2015.12GA16952.9 ± 9.789/80NANA52.5 ± 9.3LIA18751.4 ± 9.193/94NANA48.1 ± 9.9Yukawa Y2005JapanNALIA2258.9 ± 14.515/760.3 ± 9.5159.2 ± 7.9160.7 ± 27.0EA2359.1 ± 15.210/1359.0 ± 9.7160.1 ± 8.7157.5 ± 29.5Abbreviations: PONV: post-operative nausea or vomiting; GA: general anesthesia; LIA: local infiltration analgesia; ISB: interscalene block; EA: epidural anesthesia; NBA: nerve block analgesia; SA: spinal anesthesia; min: minutes; \*: mean ± standard deviation/median(min-max)

Network meta-analyses for adverse effects after orthopedic surgery {#Sec9}
------------------------------------------------------------------

According to the extracted data, parameters of ADDIS were set as follows: Number of chains: 4, Tuning iterations: 20000, Simulation iterations: 50000, Thinning interval: 10, Inference samples: 10000, Variance scaling factor: 2.5, and the network meta-analyses for PONV, urine retention, sore throat, back pain and headache were analyzed.

Network analysis for PONV {#Sec10}
-------------------------

For PONV, the PSRF value was ranged from 1.00 to 1.01, indicating model had a good convergence. The node-splitting analysis presented that *P* values of all comparisons were more than 0.05 (Table [2A](#Tab2){ref-type="table"}), and the consistency model was used to calculate the pooled effect sizes. The result presented that NBA had lowest influence on PONV after orthopedic surgery, and GA presented the worst effect on PONV after orthopedic surgery (Fig. [2A](#Fig2){ref-type="fig"}). Compared with NBA group, SA (OR = 0.31, 95%CI: 0.10, 0.86), EA (OR = 0.17, 95%CI: 0.06--0.39), GA (OR = 0.07, 95%CI: 0.02--0.18), and GA + IBS (OR = 0.19, 95%CI: 0.04--0.81) presented significantly worse effect on PONV after orthopedic surgery (Table [3A](#Tab3){ref-type="table"}).Table 2Node-splitting analysis for PONV and urine retentionNameDirect EffectIndirect EffectOverall*P*-ValueA: PONV EA, GA1.02 (−0.47, 2.42)0.88 (−0.31, 2.09)0.91 (0.02, 1.88)0.89 EA, SA0.25 (−1.15, 1.85)−1.24 (−2.46, −0.20)−0.68 (−1.58, 0.25)0.10 EA, LIA−2.46 (−4.33, − 0.74)−1.38 (−2.44, − 0.38)−1.74 (−2.67, − 0.89)0.29 EA, NBA−2.03 (−4.03, − 0.76)−1.46 (− 2.79, − 0.21)−1.80 (− 2.82, − 0.93)0.47 GA, LIA− 2.43 (− 4.62, − 0.74)−2.77 (−3.90, − 1.76)−2.64 (−3.70, − 1.75)0.78 GA, NBA−1.80 (− 4.09, − 0.11)− 2.95 (− 4.22, − 1.99)− 2.71 (−3.88, − 1.74)0.41 GA, SA−1.78 (− 2.62, − 0.96)−0.91 (− 2.41, 0.54)−1.57 (− 2.27, − 0.88)0.30 GA + ISB, ISB− 1.03 (− 3.23, 0.72)−1.62 (− 3.68, 0.32)−1.23 (− 2.76, 0.23)0.65 LIA, SA0.83 (− 0.50, 2.13)1.29 (0.13, 2.66)1.08 (0.20, 2.04)0.62 LIA, NBA− 0.08 (− 0.90, 0.65)0.04 (−1.68, 1.49)−0.07 (− 0.81, 0.63)0.89B: Urine retention EA, GA−0.47 (− 2.91, 1.86)−1.37 (− 4.68, 1.53)−0.68 (− 2.52, 0.87)0.60 EA, NBA−2.93 (−5.49, − 0.99)− 1.35 (−5.92, 2.38)−2.59 (− 4.56, − 1.00)0.45 EA, SA−0.66 (− 4.75, 2.23)−0.67 (− 3.34, 1.44)−0.76 (− 2.71, 0.86)0.96 GA, SA0.20 (− 1.68, 2.06)− 0.94 (− 4.47, 2.55)−0.08 (− 1.60, 1.43)0.55 NBA, SA0.81 (− 2.34, 4.35)2.50 (− 0.56, 5.47)1.84 (− 0.26, 3.93)0.48Abbreviations: PONV: post-operative nausea or vomiting; GA: general anesthesia; LIA: local infiltration analgesia; ISB: interscalene block; EA: epidural anesthesia; NBA: nerve block analgesia; SA: spinal anesthesia. Data was presented with odds ratio and 95% confidence intervalFig. 2Network meta-analyses for PONV and urine retention. **a**, Network meta-analyses for PONV; **b**, Network meta-analyses for urine retention. PONV: post-operative nausea or vomiting; GA: general anesthesia; LIA: local infiltration analgesia; ISB: interscalene block; EA: epidural anesthesia; NBA: nerve block analgesia; SA: spinal anesthesiaTable 3Network meta-analyses for PONV and urine retentionA: PONV EA2.48 (1.02, 6.55)0.85 (0.23, 3.54)0.26 (0.05, 1.17)0.18 (0.07, 0.41)0.17 (0.06, 0.39)0.51 (0.21, 1.29) 0.40 (0.15, 0.98)GA0.34 (0.13, 0.97)0.10 (0.03, 0.36)0.07 (0.02, 0.17)0.07 (0.02, 0.18)0.21 (0.10, 0.42) 1.17 (0.28, 4.42)2.91 (1.03, 7.79)GA + ISB0.29 (0.06, 1.25)0.20 (0.05, 0.76)0.19 (0.04, 0.81)0.59 (0.17, 1.94) 3.81 (0.86, 18.19)9.67 (2.78, 36.55)3.42 (0.80, 15.77)ISB0.68 (0.14, 3.40)0.63 (0.11, 3.34)2.02 (0.48, 8.87) 5.71 (2.44, 14.43)13.98 (5.74, 40.29)4.91 (1.32, 21.15)1.48 (0.29, 7.31)LIA0.93 (0.44, 1.87)2.95 (1.22, 7.69) 6.02 (2.53, 16.79)15.08 (5.69, 48.64)5.24 (1.24, 25.69)1.58 (0.30, 8.71)1.07 (0.53, 2.26)NBA3.22 (1.16, 9.67) 1.97 (0.78, 4.85)4.82 (2.40, 9.66)1.69 (0.52, 5.87)0.49 (0.11, 2.08)0.34 (0.13, 0.82)0.31 (0.10, 0.86)SAB: Urine retention EA0.51 (0.08, 2.38)0.10 (0.01, 1.18)0.07 (0.01, 0.37)0.47 (0.07, 2.37) 1.98 (0.42, 12.43)GA0.21 (0.01, 3.65)0.15 (0.02, 1.36)0.92 (0.20, 4.18) 9.84 (0.84, 151.97)4.87 (0.27, 82.03)LIA0.71 (0.11, 5.12)4.34 (0.25, 77.47) 13.36 (2.73, 95.12)6.83 (0.74, 57.95)1.41 (0.20, 9.26)NBA6.27 (0.77, 51.01) 2.14 (0.42, 15.04)1.09 (0.24, 4.94)0.23 (0.01, 3.95)0.16 (0.02, 1.29)SAPONV: post-operative nausea or vomiting; GA: general anesthesia; LIA: local infiltration analgesia; ISB: interscalene block; EA: epidural anesthesia; NBA: nerve block analgesia; SA: spinal anesthesia. Data was presented with odds ratio and 95% confidence interval

Network analysis for urine retention {#Sec11}
------------------------------------

The PSRF for urine retention was ranged from 1.00 to 1.02 indicating a good convergence for PSRF. Node-splitting analysis presented that *P* \> 0.05, thus, the consistency model was used to calculate the pooled effect size of urine retention (Table [2B](#Tab2){ref-type="table"}). The network analysis presented that the NBA group presented the lowest incidence of urine retention, and its incidence was significantly lower than that in the EA group (OR = 0.07, 95%CI: 0.01--0.37, Table [3B](#Tab3){ref-type="table"} and Fig. [2B](#Fig2){ref-type="fig"}).

Analysis for sore throat {#Sec12}
------------------------

For sore throat, all PSRF values were 1.01, indicating a good convergence. Because no closed ring formed, consistency model was utilized to calculate the pooled side effect of sore throat. The analytical results presented that both the SA and NBA groups had lower incidences of sore throat, but no significant differences were identified compared with other groups (Fig. [3](#Fig3){ref-type="fig"}**,** Table [4](#Tab4){ref-type="table"}).Fig. 3Network meta-analyses for sore throat. GA: general anesthesia; LIA: local infiltration analgesia; ISB: interscalene block; NBA: nerve block analgesia; SA: spinal anesthesiaTable 4Network meta-analysis for sore throatGA0.18 (0.00, 107.05)0.05 (0.00, 36.33)0.09 (0.00, 4.78)5.43 (0.01, 3647.30)ISB0.25 (0.00, 2894.67)0.48 (0.00, 868.90)20.89 (0.03, 21,288.40)3.93 (0.00, 56,736.22)NBA1.74 (0.00, 5921.00)11.51 (0.21, 588.42)2.09 (0.00, 4009.84)0.57 (0.00, 1205.54)SAGA: general anesthesia; ISB: interscalene block; NBA: nerve block analgesia; SA: spinal anesthesia. Data was presented with odds ratio and 95% confidence interval

Analysis for back pain {#Sec13}
----------------------

For back pain, all PSRF values were 1.01, indicating a good convergence. Because no closed ring formed, consistency model was utilized to calculate the pooled side effect of back pain. Compared with the EA group, both ISB (OR = 0.00, 95%CI: 0.00--0.30) and LIA (OR = 0.00, 95%CI: 0.00--0.25) groups presented lower incidences of back pain; however, no other significant difference was identified in comparison between other groups (Fig. [4A](#Fig4){ref-type="fig"}**,** Table [5A](#Tab5){ref-type="table"}).Fig. 4Network meta-analyses for back pain and headache. **a**, Network meta-analyses for back pain; **b**, Network meta-analyses for headacheGA: general anesthesia; LIA: local infiltration analgesia; ISB: interscalene block; EA: epidural anesthesia; SA: spinal anesthesia.Table 5Network meta-analyses for back pain and headacheA: Back pain EA0.02 (0.00, 0.57)0.04 (0.00, 2.38)0.00 (0.00, 0.30)0.00 (0.00, 0.25)0.06 (0.00, 1.38) 51.32(1.75,3339.72)GA1.79 (0.14, 23.31)0.20 (0.01, 3.35)0.18 (0.00, 5.98)2.98 (0.75, 20.40) 27.51(0.42,4086.82)0.56 (0.04, 7.20)GA + ISB0.12 (0.01, 1.81)0.10 (0.00, 8.09)1.69 (0.10, 43.87) 267.22(3.36,44,447.31)4.89 (0.30, 104.69)8.53 (0.55, 176.80)ISB0.82 (0.01, 96.19)15.26 (0.73, 591.84) 306.91(3.94,62,665.12)5.69 (0.17, 374.21)10.33(0.12,1263.02)1.22 (0.01, 173.76)LIA17.27 (0.82, 906.94) 15.74 (0.72, 650.35)0.34 (0.05, 1.33)0.59 (0.02, 9.74)0.07 (0.00, 1.37)0.06 (0.00, 1.22)SAB: Headache GA0.32 (0.00, 25.48)0.42 (0.10, 1.60) 3.17 (0.04, 217.06)LIA1.39 (0.02, 63.62) 2.40 (0.63, 10.17)0.72 (0.02, 55.14)SAGA: general anesthesia; LIA: local infiltration analgesia; ISB: interscalene block; EA: epidural anesthesia; SA: spinal anesthesia. Data was presented with odds ratio and 95% confidence interval

Analysis for headache {#Sec14}
---------------------

For back pain, all PSRF values were 1.01, indicating a good convergence. Because no closed ring formed, consistency model was utilized to calculate the pooled side effect of back pain. The network analysis presented that LIA group had the lowest incidence of headache, but no significant difference was revealed compared with other groups (Fig. [4B](#Fig4){ref-type="fig"}**,** Table [5B](#Tab5){ref-type="table"}).

Discussion {#Sec15}
==========

According to the selective criteria, a total of 23 studies with 2393 patients were enrolled in this study. With the network meta-analysis, patients undergoing NBA presented lower occurrence rates of PONV and urine retention compared with patients managed with SA, EA, GA, and GA + ISB during the perioperative period of orthopedic surgery. Meanwhile, patients managed with ISB and LIA were presented a significant lower occurrence rate of back pain compared with patients undergoing EA. However, there was no significant difference identified in the occurrence of headache among these groups.

NBA is a common anesthesia method utilized in orthopedic surgery, such as total knee arthroplasty \[[@CR38]\], shoulder arthroscopy \[[@CR39]\], and hip fracture \[[@CR40]\]. It has been revealed that nerve blocks may present some benefits in lower risk of PONV, enhanced pain relief and earlier discharge \[[@CR41], [@CR42]\]. Park et al. have demonstrated that interscalene brachial plexus block could significantly reduce the nausea and vomiting, while suprascapular nerve anesthesia and intra-articular local anesthesia can't reduce the nausea and vomiting compared with the non-pain controlled group \[[@CR43]\]. Hadzic et al. have identified that NBA can reduce the PONV compared with the general anesthesia for patients undergoing outpatients rotator cuff surgery \[[@CR44]\]. During podiatric surgery in children, patients managed with EA present a higher risks for adverse events, including PONV and urine retention \[[@CR18]\]. However, a previous meta-analysis has summarized that patients managed with NBA present a lower incidence of urine retention than patients undergoing EA, but there is no difference in the incidence of PONV \[[@CR45]\]. With an updated meta-analysis, NBA was identified to put a significant lower effects on the occurrence rates of PONV, urine retention, and sore throat compared with patients managed with SA, EA, GA, and GA + ISB during the perioperative period of orthopedic surgery in the current study. All of these findings indicated that NBA might perform a better outcome on the prognosis of patients undergoing orthopedic surgery.

ISB is one of the most reliable and commonly anesthetic method applied for the upper extremity with less opioid consumption and opioid-associated adverse effect \[[@CR46]\]. Meanwhile, LIA is a safety and effective method for pain control during the perioperative periods of knee and hip surgery \[[@CR47]\]. In this study, patients managed with ISB and LIA presented a significant lower occurrence rate of back pain compared with patients undergoing EA, indicating that ISB and LIA might play a better outcome for relieving back pain during orthopedic surgery. Adersen et al. have revealed that LIA presents a superior outcome with less adverse effect, including pain control, than EA during total knee arthroplasty \[[@CR48]\]. Another study has also demonstrated that LIA performs a better outcome in pain controlling during total knee arthroplasty \[[@CR49]\]. These findings demonstrated LIA and ISB might perform effective roles in relieving pains, such as back pain, during the perioperative period of orthopedic surgery. Despite of these, LIA was also identified to play critical role in relieving headache during the perioperative period of orthopedic surgery, but no statistically difference was identified compared with other group. Therefore, further investigation with large sample size might be required.

Although this study was the first to compare the effects of different anesthesia methods on the complications of orthopedic surgery, but there were still some limitations in this study. First, due to the incomplete data in studies, correction of concomitant variables was not performed, which might affect the results identified in this study. Meanwhile, the subgroup analysis was also not conducted. Second, limited by the property of ADDIS, the calculation of pooled effect size might be influenced. Third, some complications, such as headache and back pain, were not reported in several anesthesia methods; thus, there might be some bias contained in this study.

Conclusions {#Sec16}
===========

In conclusion, according to the network analysis, NBA was a superior anesthesia method in reliving the occurrence of PONV, urine retention, and sore throat compared with patients managed with SA, EA, GA, and GA + ISB during the perioperative period of orthopedic surgery. ISB and LIA were two effective anesthesia methods in lowering the occurrence rate of back pain during the perioperative period of orthopedic surgery. Therefore, it is important to surgeons to select appropriate anesthesia methods during the perioperative period of orthopedic surgery according to the physical fitness of patients and the effects of anesthesia methods on the occurrence of complications.
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